Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
doi:10.1038/sj.bjc.6690404 Tanzilli G, Arrivi A, Placanica A, et al
A goal of BrSM would be to eventually develop biomarkers tailored to individual pathophysiological disease states that predict the health-disease continuum and allow for therapeutic interventions at the specific stage of a patients disease
A key feature of the program is the cost-sharing structure
Physiology, Postpartum Changes
Butylated hydroxyanisole increases glutathione-S-transferase activity in hepatocyte [PMID: 2285245] Laboratory literature summary: Butylated hydroxyanisole increases glutathione-S-transferase activity in hepatocyte culture
Type 2 diabetes | Treatment summaries BNF NICE
US$ 27.61
US$ 27.93
US$ 22.46
US$ 22.60
US$ 27.39
US$ 27.45
US$ 23.95
US$ 26.36
